Stockreport

Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF of lunresertib and camonsertib to treat adult patients with CCNE1 amplified, or FBXW7 or PPP2R1A-mutated platinum-resistant ovarian cancer. The FDA's Fast Track design [Read more]